Immunome Cash Flow Statement (2019-2026) | IMNM

Cash Flow Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-26.04M-7.72M-7.84M-11.75M-10.73M-11.93M-8.08M-4.57M-16.07M-15.83M-94.67M-132.40M-86.23M-116.13M-83.27M-44.90M-70.30M-101.90M-73.10M-244.25M
Share-based Compensation (Quarter)
0.75M1.16M1.22M1.31M1.33M1.34M1.35M1.22M1.03M1.08M1.10M2.16M3.23M4.89M5.47M5.70M5.35M6.75M7.89M7.95M
Gains from Investment Securities (Quarter)
Cash from Operations (Quarter)
-3.74M-4.14M-6.80M-6.38M-8.06M-7.57M-6.68M24.17M-5.67M-8.61M-17.46M-11.17M-23.40M-34.17M-42.06M-53.05M-49.40M-40.51M-47.95M-58.64M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.84M0.54M0.35M1.47M0.54M0.82M1.21M0.82M
Amortization of Deferred Charges (Quarter)
0.03M0.01M0.01M0.17M0.05M0.06M0.06M0.11M0.11M0.12M0.16M0.14M0.12M0.08M0.14M0.15M0.15M
Depreciation & Amortization (CF) (Quarter)
0.17M0.29M0.12M0.11M0.11M0.10M0.07M0.09M0.10M0.11M0.19M0.16M0.55M0.41M0.48M0.61M0.64M0.59M0.66M0.60M
Change in Working Capital
Change in Account Payables (Quarter)
-1.28M1.60M-0.31M0.79M1.39M-2.12M-0.74M0.69M0.59M-1.21M-0.68M2.40M-0.03M-2.11M9.27M-3.81M-4.95M1.87M-2.28M1.42M
Change in Accured Expenses (Quarter)
0.52M2.50M2.47M-0.91M-2.43M0.87M0.55M-1.40M1.37M-1.42M2.07M0.67M6.90M5.94M0.04M-8.52M0.62M6.74M5.70M-9.75M
Other Working Capital Changes (Quarter)
-1.84M1.96M2.46M-3.97M-0.47M-0.79M0.17M-0.21M-1.00M-0.34M5.70M-2.47M1.60M-1.39M1.36M1.71M3.60M-1.86M0.04M5.10M
Investing Activities
Capital Expenditures (Quarter)
-0.02M-0.01M0.08M0.01M0.17M0.07M0.22M0.22M-0.13M0.06M0.59M3.91M1.54M1.13M3.67M-2.38M4.40M4.00M3.00M
Change in Acquisitions & Divestments (Quarter)
30.00M85.00M15.00M60.00M125.00M
Cash from Investing Activities (Quarter)
-0.01M-0.03M-0.01M-0.01M-0.17M-0.07M-0.11M-0.34M-0.04M-30.00M-37.23M-81.69M24.10M9.76M5.09M-64.17M123.88M-4.00M-12.02M
Financing Activities
Other financing activities (Quarter)
0.02M0.05M0.03M0.03M64.00M3.43M0.30M-1.71M0.21M-0.21M0.23M
Cash from Financing Activities (Quarter)
27.30M0.58M-0.20M0.03M0.03M60.88M55.50M219.44M0.69M0.30M20.09M162.23M-0.06M45.39M432.80M-0.14M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
0.80M0.03M125.00M20.00M44.90M0.43M
Additional items
Change in Cash (Quarter)
23.55M-3.59M-7.01M-6.35M-8.23M-7.57M-6.75M24.10M-6.01M52.23M8.04M171.04M-104.39M-9.76M-12.22M114.26M-113.63M128.76M380.84M-70.79M
Free Cash Flow (Quarter)
-3.72M-4.14M-6.88M-6.38M-8.23M-7.57M-6.75M23.95M-5.89M-8.48M-17.52M-11.76M-27.31M-35.71M-43.19M-56.72M-47.02M-44.91M-51.95M-61.64M
Net Cash Flow (Quarter)
23.55M-3.59M-7.01M-6.35M-8.23M-7.57M-6.75M24.10M-6.01M52.23M8.04M171.04M-104.39M-9.76M-12.22M114.26M-113.63M128.76M380.84M-70.79M